Trial intelligence / Profile preview

FASTERCC: Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

NCT03581773Phase 2Completed

Start
Dec 2017
Primary completion
Sep 2026
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of folic acid in mucositis, stomatitis. Started Dec 2017; status: completed.

02

Drugs

folic acid
03

Conditions

mucositisstomatitis

Beyond the preview

Go deeper on NCT03581773.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03581773.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call